Question

Is stem cell therapy for Parkinson's Disease covered by insurance?

Insurance covers established Parkinson's medications and surgery, not stem-cell therapy, which is self-pay. Some academic centres enrol patients in registered trials without charge, offering access to potential new therapies within a research framework.

The cost picture for Parkinson's Disease

Indicative European costs are roughly €4,000–€7,000 per infusion. If intracerebral delivery is used, stereotactic neurosurgery, imaging and intensive monitoring can double or triple the total. Some protocols use multiple infusions over months. For context, medical management runs €200–€1,000 monthly and deep-brain stimulation is a large one-time cost — the stem-cell figure is indicative and unproven.

Am I a candidate? → · Parkinson's Disease: full overview → · Parkinson's Disease cost → · Cost →

Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.

Terapia celular de nivel europeo, sin precios europeos.

Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.

Evaluación médica gratuita